BVS

Bioventus Inc. · NASDAQ · Healthcare · USD · 10-K for 2025, filed 2026-03-05

Figures on this page computed 2026-11-08 12:01 UTC

Last close

10.61USD

Market data, 2026-11-06

BVS: weekly closes from 7.45 on 2025-11-07 to 10.61 on 2026-11-06, a move of +42.4%. Prices in USD.

Weekly closes, 2025-11-07 to 2026-11-06

Over that span: +42.4%

Except where said otherwise: 10-K for 2025, filed 2026-03-05

31.2xP/E
Price / Earnings per Share (diluted)
Source
computed
Fiscal year
2025
Accession
0001665988-26-000011
Reported in
USD
- computed
- 10-K for 2025, filed 2026-03-05
The filing itself
n/aROIC
We do not hold this figure for this company, so there is nothing to place.
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
Source
computed
Fiscal year
2025
Accession
0001665988-26-000011
Reported in
USD
- 10-K for 2025, filed 2026-03-05
- 10-K for 2025, filed 2026-03-05
- 10-K for 2025, filed 2026-03-05
- 10-Q for 2025, filed 2026-11-02
- 10-K for 2025, filed 2026-03-05
- 10-Q for 2025, filed 2026-11-02
The filing itself
4.0%Net margin
Net Income / Revenue x 100
Source
computed
Fiscal year
2025
Accession
0001665988-26-000011
Reported in
USD
- 10-K for 2025, filed 2026-03-05
- 10-K for 2025, filed 2026-03-05
The filing itself
12.7%FCF margin
Free Cash Flow / Revenue x 100
Source
computed
Fiscal year
2025
Accession
0001665988-26-000011
Reported in
USD
- 10-K for 2025, filed 2026-03-05
- 10-K for 2025, filed 2026-03-05
The filing itself
1.69Debt/equity
Total Debt / Shareholders' Equity
Source
computed
Fiscal year
2025
Accession
0001665988-26-000011
Reported in
USD
- 10-K for 2025, filed 2026-03-05
- 10-Q for 2025, filed 2026-11-02
The filing itself
n/aDividend yield
We do not hold this figure for this company, so there is nothing to place.
Source
computed
Taken on
2026-11-07
Reported in
USD
- computed

Safety is the furthest below its sector's middle: 0.36 against 0.58 on the market's range.

What it pays out: n/aWe do not hold this figure for this company, so there is nothing to place.

Five bars, one line

lens 7 of 9

1.37x

-0.72x

2.35x

0.95x

1.22x

SalesProfitFree cash flowDebtPrice

Each bar against this company's own average; the line is that average.

Filed2025

Market data2026-11-06

Each against its own average

5 of 5 read

Except where said otherwise: 10-K for 2025, filed 2026-03-05

Sales1.37x
Its own average over 10 years, 414.4M.
Profit-0.72x
Its own average over 10 years, -31.7M.
Free cash flow2.35x
Its own average over 8 years, 30.6M.
Debt0.95x
Its own average over 7 years, 328.5M.
Price1.22x
Its own average over 6 years, 9. Market data, 2026-11-06

Profit is furthest from its own average, at -0.72 times.

The filed years, as a table

Each line is 100 at 2016-12-31, the first year we hold.

Filed year	Sales	Shares in issue
2016-12-31	100.0	100.0
2017-12-31	106.4	100.0
2018-12-31	116.3	100.0
2019-12-31	123.9	n/a
2020-12-31	117.0	n/a
2021-12-31	157.0	80.0
2022-12-31	186.6	108.0
2023-12-31	186.6	110.2
2024-12-31	208.8	113.6
2025-12-31	207.0	121.3

How sales was got

Source: filed
Statement: income
Fiscal year: 2025
Accession: 0001665988-26-000011
Reported in: USD

The filing itself

How shares in issue was got

Source: filed
Statement: income
Fiscal year: 2025
Accession: 0001665988-26-000011
Reported in: USD

The filing itself

Figures behind the shape

Growth

12.1%

faster is higher, placed against 4,950 companies as of 2026-11-07

Five-year revenue growth rate12.1%
Source
computed
Taken on
2026-11-07
Reported in
USD
- computed
Five-year EPS growth raten/a
We do not hold this figure for this company, so there is nothing to place.
Source
computed
Taken on
2026-11-07
Reported in
USD
- computed
One-year change in net income162.9%
Source
computed
Taken on
2026-11-07
Reported in
USD
- computed

Returns on capital

12.3%

higher is higher, placed against 5,089 companies as of 2026-11-07

Return on invested capitaln/a
We do not hold this figure for this company, so there is nothing to place.
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
Source
computed
Fiscal year
2025
Accession
0001665988-26-000011
Reported in
USD
- 10-K for 2025, filed 2026-03-05
- 10-K for 2025, filed 2026-03-05
- 10-K for 2025, filed 2026-03-05
- 10-Q for 2025, filed 2026-11-02
- 10-K for 2025, filed 2026-03-05
- 10-Q for 2025, filed 2026-11-02
The filing itself
Return on equity12.3%
Net Income / Shareholders' Equity x 100
Source
computed
Fiscal year
2025
Accession
0001665988-26-000011
Reported in
USD
- 10-K for 2025, filed 2026-03-05
- 10-Q for 2025, filed 2026-11-02
The filing itself
Return on assets3.3%
Net Income / Total Assets x 100
Source
computed
Fiscal year
2025
Accession
0001665988-26-000011
Reported in
USD
- 10-K for 2025, filed 2026-03-05
- 10-Q for 2025, filed 2026-11-02
The filing itself

Margins

68.3%

wider is higher, placed against 3,412 companies as of 2026-11-07

Gross margin68.3%
Gross Profit / Revenue x 100
Source
computed
Fiscal year
2025
Accession
0001665988-26-000011
Reported in
USD
- 10-K for 2025, filed 2026-03-05
- 10-K for 2025, filed 2026-03-05
The filing itself
Operating margin9.5%
Operating Income / Revenue x 100
Source
computed
Fiscal year
2025
Accession
0001665988-26-000011
Reported in
USD
- 10-K for 2025, filed 2026-03-05
- 10-K for 2025, filed 2026-03-05
The filing itself
Net margin4.0%
Net Income / Revenue x 100
Source
computed
Fiscal year
2025
Accession
0001665988-26-000011
Reported in
USD
- 10-K for 2025, filed 2026-03-05
- 10-K for 2025, filed 2026-03-05
The filing itself
Free cash flow margin12.7%
Free Cash Flow / Revenue x 100
Source
computed
Fiscal year
2025
Accession
0001665988-26-000011
Reported in
USD
- 10-K for 2025, filed 2026-03-05
- 10-K for 2025, filed 2026-03-05
The filing itself

Price

31.2x

cheaper is higher, placed against 4,362 companies as of 2026-11-07

Price to earnings31.2x
Price / Earnings per Share (diluted)
Source
computed
Fiscal year
2025
Accession
0001665988-26-000011
Reported in
USD
- computed
- 10-K for 2025, filed 2026-03-05
The filing itself
Price to book4.0x10-Q for 2025, filed 2026-11-02
Price / Book Value per Share, where BVPS = Shareholders' Equity / Diluted Shares
Source
computed
Fiscal year
2025
Accession
0001665988-26-000052
Reported in
USD
- computed
- 10-Q for 2025, filed 2026-11-02
- computed
- 10-K for 2025, filed 2026-03-05
The filing itself
EV to EBITDA9.8x
Enterprise Value / EBITDA, where EV = Market Cap + Total Debt - Cash
Source
computed
Fiscal year
2025
Accession
0001665988-26-000011
Reported in
USD
- computed
- 10-K for 2025, filed 2026-03-05
- 10-K for 2025, filed 2026-03-05
- 10-Q for 2025, filed 2026-11-02
- 10-K for 2025, filed 2026-03-05
The filing itself
Price to sales ratio1.3x
Market Cap / Revenue, where Market Cap = Price x Diluted Shares
Source
computed
Fiscal year
2025
Accession
0001665988-26-000011
Reported in
USD
- computed
- 10-K for 2025, filed 2026-03-05
- 10-K for 2025, filed 2026-03-05
The filing itself

Safety

1.69

safer is higher, placed against 3,227 companies as of 2026-11-07

Debt to equity1.69
Total Debt / Shareholders' Equity
Source
computed
Fiscal year
2025
Accession
0001665988-26-000011
Reported in
USD
- 10-K for 2025, filed 2026-03-05
- 10-Q for 2025, filed 2026-11-02
The filing itself
Current ratio1.7010-Q for 2025, filed 2026-11-02
Current Assets / Current Liabilities
Source
computed
Fiscal year
2025
Accession
0001665988-26-000052
Reported in
USD
- 10-Q for 2025, filed 2026-11-02
- 10-Q for 2025, filed 2026-11-02
The filing itself
Interest coveragen/a
We do not hold this figure for this company, so there is nothing to place.
Operating Income / Interest Expense
Source
computed
Fiscal year
2025
Accession
0001665988-26-000011
Reported in
USD
- 10-K for 2025, filed 2026-03-05
- 10-K for 2025, filed 2026-03-05
The filing itself
Altman Z-Score1.57
1.2 x A + 1.4 x B + 3.3 x C + 0.6 x D + 1.0 x E (A=WC/TA, B=RE/TA, C=EBIT/TA, D=MktCap/TL, E=Rev/TA)
Source
computed
Taken on
2026-11-07
Reported in
USD
- Computed from the 10-K for 2025, filed 2026-03-05
- Computed from the 10-K for 2025, filed 2026-03-05
- Computed from the 10-K for 2025, filed 2026-03-05
- Computed from the 10-K for 2025, filed 2026-03-05
- Computed from the 10-K for 2025, filed 2026-03-05

What it pays out

n/a

We do not hold this figure for this company, so there is nothing to place.

more, and better covered, is higher, with no cohort held

Dividend yieldn/a
We do not hold this figure for this company, so there is nothing to place.
Source
computed
Taken on
2026-11-07
Reported in
USD
- computed
Payout ration/a
We do not hold this figure for this company, so there is nothing to place.
Common Dividends Paid / Net Income x 100, both from the latest filed fiscal year
Source
computed
Fiscal year
2025
Accession
0001665988-26-000011
Reported in
USD
- 10-K for 2025, filed 2026-03-05
- Computed from the 10-K for 2025, filed 2026-03-05
- 10-K for 2025, filed 2026-03-05
The filing itself
Dividend cover ration/a
We do not hold this figure for this company, so there is nothing to place.
Source
computed
Taken on
2026-11-07
Reported in
USD
- computed

Share a finding

A link to the finding, not to you: it carries nothing about your account.